Earnings Per Share, Basic in USD/shares of Gain Therapeutics, Inc. from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Gain Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q2 2020 to Q3 2025.
  • Gain Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was 0 USD/shares, a 11.8% increase year-over-year.
  • Gain Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 0 USD/shares, a 47.3% increase year-over-year.
  • Gain Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was 0 USD/shares, a 48% increase from 2023.
  • Gain Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1 USD/shares, a 15.5% decline from 2022.
  • Gain Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1 USD/shares, a 8.03% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Gain Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0 +$0.02 +11.8% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $0 $0 +$0.23 +54.8% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $0 $0 +$0.06 +27.3% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $0 $0 +$0.21 +72.4% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025
Q3 2024 -$1 $0 +$0.2 +54.1% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$1 $0 +$0.2 +32.3% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$1 $0 +$0.21 +48.8% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 -$1 $0 +$0.1 +25.6% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 -$1 $0 +$0.01 +2.6% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$1 $0 -$0.19 -44.2% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$1 $0 -$0.15 -53.6% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$1 $0 -$0.21 -1.2% 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024
Q3 2022 -$1 $0 +$0.01 +2.6% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$1 $0 -$0.13 -43.3% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$1 $0 +$0.22 +44% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$1 $0 01 Oct 2021 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 $0 -$0.14 -56% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $0 -$0.03 -11.1% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 $0 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q3 2020 $0 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $0 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021

Gain Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 +$0.82 +48% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 -$1 -$0.23 -15.5% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
2022 -$1 -$0.11 -8% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024
2021 -$1 -$0.04 -3% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023
2020 -$1 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.